Purpose To understand the consequences of the 3q29 deletion on medical, neurodevelopmental,
psychiatric, brain structural, and neurological sequalae by systematic evaluation of …

Asparagine‐linked glycosylation 13 homolog (ALG13) encodes a nonredundant, highly
conserved, X‐linked uridine diphosphate (UDP)‐N‐acetylglucosaminyltransferase required for …

Background 3q29 deletion syndrome is caused by a recurrent hemizygous 1.6 Mb deletion
on the long arm of chromosome 3. The syndrome is rare (1 in 30,000 individuals) and is …

Purpose Lamb–Shaffer syndrome (LAMSHF) is a neurodevelopmental disorder described in
just over two dozen patients with heterozygous genetic alterations involving SOX5, a gene …

Heterozygous missense variants in TRAF7 lead to various cancers when somatic and a multiple
congenital anomalies--intellectual disability syndrome (MCA-IDS) when germline (1, 2). …

GeneReviews, an international point-of-care resource for busy clinicians, provides clinically
relevant and medically actionable information for inherited conditions in a standardized …

3q29 deletion syndrome (3q29del) is a rare genomic disorder caused by a 1.6 Mb deletion (hg19,
chr3:195725000–197350000). 3q29del is associated with neurodevelopmental and …

3q29 deletion syndrome (3q29del) is a recurrent deletion syndrome associated with
neuropsychiatric disorders and congenital anomalies. Dysmorphic facial features have been …

Background 3q29 deletion syndrome is associated with a range of medical, neurodevelopmental,
and psychiatric phenotypes. The deletion is usually de novo but cases have been …

Background Arginase 1 Deficiency (ARG1-D) is a rare debilitating, progressive, inherited,
metabolic disease characterized by marked increases in plasma arginine (pArg) and its …